Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab + Cisplatin + Topotecan in Advanced Cervical Cancer
NCT00518193Phase 2Terminated
- Sponsor
- ARCAGY
- Start
- Apr 2007
- Primary completion
- Jul 2007
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of cetuximab in Cervical Cancer (CC), sponsored by ARCAGY. Started Apr 2007; status: terminated.
02
Drugs
cetuximab
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT00518193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00518193.